Metropolitan Life Insurance CO Vista Gen Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jun 20, 2023	BUY	$0.88 - $1.73 $13,368 - $26,282	15,192 New	15,192 $13,000
Q1 2022 Jun 20, 2023	BUY	$1.14 - $2.09 $17,318 - $31,751	15,192 New	15,192 $18,000
Q1 2022 Mar 30, 2023	SELL	$1.14 - $2.09 $56,081 - $102,815	-49,194 Reduced 76.4%	15,192 $18,000
Q1 2022 May 12, 2022	SELL	$1.14 - $2.09 $56,081 - $102,815	-49,194 Reduced 76.4%	15,192 $19,000
Q4 2021 Jun 21, 2023	BUY	$1.67 - $2.76 $107,524 - $177,705	64,386 New	64,386 $125,000

Q3 2021 Jun 21, 2023	BUY	$2.62 - $3.45 $168,691 - $222,131	64,386 New	64,386 $176,000
Q2 2021 Jun 21, 2023	BUY	$1.96 - $3.15 $126,196 - $202,815	64,386 New	64,386 $202,000
Q2 2021 Mar 30, 2023	BUY	$1.96 - $3.15 $126,196 - $202,815	64,386 New	64,386 $202,000
Q2 2021 Aug 16, 2021	BUY	$1.96 - $3.15 $126,196 - $202,815	64,386 New	64,386 $203,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $730M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.